Oncology

Biomedical

Assessment of reproducibility of cancer survival risk predictions across medical centers


Background

Two key considerations in evaluating survival prediction models are predictability (the ability to accurately predict survival risks) and reproducibility (the ability to generalize predictions across studies or centers). This study explores approaches to assessing the reproducibility of survival risk predictions across medical...
2 weeks ago

Biomedical

Progesterone Exposure and Breast Cancer Risk—Addressing Barriers


...
1 month ago

Biomedical

Single Hormone Receptor–Positive Breast Cancer—Signal or Noise?


...
1 month ago

Biomedical

Predictability: A new distinguishing feature of cancer?


Cancer is a consequence of stochastic (mutations, genetic, and epigenetic instabilities) and deterministic (evolutionary bottlenecks) events. Stochastic events are less amenable to prediction, whereas deterministic events yield more predictable results. The relative contribution of these opposing forces determines cancer predictability, which affects the accuracy of our prognostic predictions and ...
2 months ago

Biomedical

Evaluation and comparison of hereditary Cancer guidelines in the population


Background Family health history (FHx) is an effective tool for identifying patients at risk of hereditary cancer. Hereditary cancer clinical practice guidelines (CPG) contain criteria used to evaluate FHx and to make recommendations for genetic consultation. Comparing different CPGs used to evaluate a common set of FHx provides insight into how well the CPGs perform, the extent of agreement acro...
2 months ago

Biomedical

The knowledge of hereditary breast cancer, and attitude and intention towards genetic testing of the patients with high-risk hereditary breast cancer


Purpose: This study aimed to explore the knowledge of hereditary breast cancer (HBC) and attitudes and intention towards genetic testing of the patients with high-risk HBC, and to describe their differences according to the intention of genetic test. Methods: High-risk HBC patients (n = 138) who did not take genetic test or relevant counseling were recruited in D city, Korea. Participants complete...
2 months ago

Biomedical

A sheep in wolf's clothing; a case of renal leiomyoma masquerading as hereditary leiomyomatosis and renal cell carcinoma


Introduction: Active surveillance has become a standard of care for the management of small renal masses. Decision to transition from surveillance to intervention relies on several factors including growth kinetics, histologic grade on biopsy and patient comorbidities. Management of renal masses in pregnancy presents a unique change when clinical triggers must be weighed with risk to fetus. We pre...
2 months ago

Biomedical

Hereditary Cancer Syndromes: Identifying and Managing High-Risk Patients


Hereditary Cancer Syndromes: Identifying and Managing High-Risk Patients...
2 months ago

Biomedical

Current status of inherited pancreatic cancer


Background It is estimated that about 10% of pancreatic cancer cases have a genetic background. People with a familial predisposition to pancreatic cancer can be divided into 2 groups. The first is termed hereditary pancreatic cancer, which occurs in individuals with a known hereditary cancer syndrome caused by germline single gene mutations (e.g.,BRCA1/2,CDKN2A). The second is considered as fami...
2 months ago

Biomedical

Advanced adenomas may be a red flag for hereditary cancer syndromes


Background: 16–25% of colorectal cancers (CRCs) diagnosed under age 50 are associated with hereditary cancer syndromes. Advanced adenomas are considered precursors to CRC. Although polyp removal prevents cancer, polypectomy does not change underlying genetic risk. Patients with isolated advanced polyps do not currently qualify for genetic testing unless they have a personal or family history of ...
2 months ago

Showing Page 1 to 2